Ms. Sboniso Mhlongo | Veterinary Public Health | Best Researcher Award
North West Department of Agriculture | South Africa
Profile: ORCID
North West Department of Agriculture | South Africa
Profile: ORCID
Dr. Hong Wang is a distinguished pediatric cardiologist based at Shengjing Hospital, China Medical University (CMU), with over three decades of expertise in pediatric cardiovascular diseases, particularly Kawasaki disease and cardiomyopathies. she has held key leadership roles including Director and Professor of the Cardiology Division in the Pediatrics Department. Her international exposure includes research training in the USA at Ohio University and Nationwide Children’s Hospital. As a renowned academician and clinician, Dr. Wang has spearheaded multiple research grants and published extensively in reputed international journals. She has authored influential monographs and holds editorial leadership positions. Her contributions to pediatric cardiology have earned her prestigious awards and positions in national medical committees. Dr. Wang’s commitment to pediatric health and academic rigor has established her as a leading voice in pediatric cardiology research in China and beyond.
Dr. Hong Wang’s educational journey spans more than two decades of specialized training in pediatric medicine. She earned her Bachelor’s degree in Pediatrics from China Medical University (CMU) in 1987, followed by a Master’s degree in Pediatrics from the same institution in 1999. She subsequently completed her Doctor of Medicine (Pediatrics) degree at CMU in 2005, solidifying her foundation in clinical and research-based pediatric cardiology. In 1999, she undertook specialized training in interventional treatment of congenital heart diseases at the Army General Hospital of the Shenyang Military Region. Furthering her academic exposure internationally, Dr. Wang conducted advanced research in Duchenne Muscular Dystrophy (DMD) cardiomyopathy at the Gene Therapy Center of Nationwide Children’s Hospital, affiliated with Ohio University, USA (2013–2014). Her diverse educational background reflects both clinical proficiency and a strong research orientation, making her a well-rounded leader in pediatric cardiology.
Dr. Wang’s professional career began in 1987 at Shengjing Hospital, CMU, as a teaching assistant and residential physician. Over the years, she rose through the ranks to hold pivotal academic and clinical leadership roles. Between 1993 and 2003, she served as a lecturer and attending physician, followed by an appointment as Associate Professor and Master’s Supervisor from 2003 to 2008. In 2008, she became a full Professor and Director of Pediatric Master Training. She held the position of Deputy Director (2010–2018) and later Director (2018–2024) of the Cardiology Division in the Pediatrics Department. She currently continues to contribute at a senior level post-2024. Her career reflects a profound commitment to pediatric cardiac care, teaching, and mentorship, influencing generations of medical students and physicians. Her leadership has significantly advanced pediatric cardiology services in China, with a focus on clinical excellence, research development, and international collaboration.
Dr. Hong Wang has been recognized with multiple prestigious honors throughout her illustrious career. She received the Third Prize of Liaoning Provincial Science and Technology Progress Award as the principal investigator and contributed to four Second Prizes as a co-researcher. Her leadership in funded research includes managing three competitive research grants—two from the Liaoning Provincial Natural Science Foundation and one from the Science and Technology Bureau of Shenyang City. She is also widely respected in academic publishing, having authored six SCI-indexed journal articles and served as editor-in-chief of two monographs published by People’s Medical Publishing House and Springer. In professional circles, Dr. Wang serves as a member of several high-level national committees in pediatric cardiology and arrhythmia, including the Chinese Medical Association and the Chinese Medical Doctor Association. These accolades underscore her dedication to excellence in pediatric research, education, and clinical care.
Dr. Wang’s research is centered on pediatric cardiovascular diseases, with special emphasis on Kawasaki disease, arrhythmias, and congenital cardiomyopathies such as DCM, EFE, and LVNC. She has led and participated in major research projects funded by national and provincial institutions, focusing on early diagnosis, imaging, interventional treatments, and molecular mechanisms underlying pediatric heart conditions. Her international collaboration in DMD cardiomyopathy research during her tenure at Nationwide Children’s Hospital (USA) introduced advanced gene therapy perspectives into her work. Her publications reflect in-depth clinical analysis, case studies, and use of diagnostic technologies such as multi-slice CT coronary angiography. Dr. Wang is also actively involved in translational research, exploring biomarkers like sST2 and anti-cardiolipin antibodies in cardiovascular pathology. Her research aims to improve early detection and optimize therapeutic strategies in pediatric cardiology, ensuring evidence-based improvements in patient care and clinical protocols across China.
Dr. Minu P. Mohan is an accomplished clinician-researcher with an interdisciplinary background in dental surgery, prosthodontics, and public health. Currently serving as a Research Scientist at the University at Buffalo, she contributes significantly to multi-site studies on cystic fibrosis, cancer psycho-oncology, and health disparities. A recipient of multiple academic honors, she earned her BDS and MDS from the University of Kerala, India, and her MPH from the University of Massachusetts Lowell. With over 15 years of experience, Dr. Mohan has held academic positions in India and Saudi Arabia and has managed NIH-funded public health research projects in the U.S. Her expertise spans clinical research management, big data analytics, oral oncology, and machine learning applications in healthcare. She has published extensively, presented at international conferences, and is known for her contributions to understanding health outcomes among vulnerable populations. Her multidisciplinary work reflects a commitment to integrating research and clinical excellence to advance health equity.
Dr. Minu P. Mohan holds three distinguished degrees. She completed her Bachelor of Dental Surgery (BDS) in 2004 from the Government Dental College, Trivandrum, under the University of Kerala, India. She went on to pursue her Master of Dental Surgery (MDS) in Prosthodontics and Crown & Bridge at the same institution from 2007 to 2010. To expand her global healthcare insight, she earned a Master of Public Health (MPH) in Healthcare Management from the University of Massachusetts Lowell (2020–2021), where she also received a Graduate Assistantship, the Tri Alpha Honors, and a Provost’s Fellowship. Her education combines rigorous clinical training, academic excellence, and research-focused public health knowledge, enabling her to transition seamlessly between dentistry, public health, and clinical research. She also participated in training on health policy and implementation science, solidifying her reputation as a well-rounded healthcare professional bridging research, policy, and clinical care.
Dr. Mohan’s career spans clinical practice, academia, and research leadership across India, Saudi Arabia, and the United States. She currently works as a Research Scientist at the University at Buffalo on multi-institutional projects related to cystic fibrosis and psycho-oncology. Previously, she served as a Clinical Research Coordinator III at Boston Medical Center, managing liver and inflammatory bowel disease trials. Earlier, she held academic roles including Assistant Professor at Qassim University, Saudi Arabia (2015–2019), and Mar Baselios Dental College, India (2011–2015), teaching prosthodontics and coordinating implantology and education quality initiatives. Her public health research roles include Graduate Research Assistant, Research Analyst, and Policy Intern at the University of Massachusetts Lowell, contributing to HIV care equity and organizational readiness initiatives. Her unique blend of clinical, academic, and analytical skills enables her to lead complex, interdisciplinary research while maintaining a patient-centered approach to healthcare innovation and education.
Dr. Minu Mohan has received numerous accolades across academic, clinical, and research domains. In 2021, she was nominated for Best Poster Award at the 14th Annual Dissemination & Implementation Science Conference. Her MPH studies were supported by the Provost’s Graduate Fellowship, Graduate Assistantship, and Tri Alpha Honors from the University of Massachusetts Lowell. During her dental residency, she won Best Scientific Paper for her work on silicone digital prostheses and Best Poster for clinical prosthetic rehabilitation cases at the 42nd Kerala State Dental Conference in 2009. Her research has since been spotlighted in global conferences such as ASCO, MASCC, and the National Ryan White Conference. She has authored or co-authored over 35 peer-reviewed journal articles and multiple conference abstracts. Her interdisciplinary projects involving AI, psycho-oncology, and public health disparities have positioned her as an award-winning thought leader in translational healthcare research.
Dr. Mohan’s research bridges clinical dentistry, oncology, and public health, with a strong emphasis on healthcare disparities, psycho-oncology, and data-driven health analytics. Her current projects involve the use of machine learning (ML) and explainable artificial intelligence (XAI) to predict suicidal ideation and cachexia in cancer patients. She also investigates opioid dependence, mental health screening, and emerging treatment toxicities using big data in hospitalized cancer cohorts. Her earlier public health research at the University of Massachusetts focused on Black Women with HIV, contributing to policy briefs and NIH-funded interventions. Additionally, she has explored prosthodontics innovations, digital prostheses, and quality-of-life outcomes post maxillofacial rehabilitation. Dr. Mohan’s work exemplifies an integrated approach, combining qualitative and quantitative research, AI applications in health, and a commitment to vulnerable populations. Her projects regularly feature in high-impact journals and global oncology conferences, contributing to evidence-based strategies in both clinical and population health domains.